News for Fusion Pharmaceuticals Inc. (FUSN)

Three growth stocks that look like fantastic buys for the long haul right now are AstraZeneca (NASDAQ: AZN), Uber Technologies (NYSE: UBER), and Arista Networks (NYSE: ANET). Here's why these can be great investments to hang on to for years. This is a stock that can be both a good growth stock and an income-generating investment.

In a sense, every investor is a growth investor. Three Motley Fool contributors think they've found magnificent growth stocks to buy right now. Here's why they picked AstraZeneca (NASDAQ: AZN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX).

AstraZeneca to invest $570m in Canada, creating 700 new jobs

We recently published a list of 10 Cheap NASDAQ Stocks To Invest In Now.

Prostate cancer is one of the most common cancers among men worldwide, especially in aging populations. The increasing global elderly population leads to...

According to Research by SNS Insider, The Radiopharmaceuticals Market growth is driven by advancements in nuclear medicine, personalized treatments, and...

In this article, we will be taking a look at the 15 unhealthiest countries in Europe.

Hepatic tumors are abnormal growth of liver cells on or in the liver. The Hepatic Tumor market is driven by several key factors reflecting the increasing...

The major U.S. index futures are currently pointing initial strength on Wall Street on Wednesday, with stocks likely to see further upside after ending yesterday's lackluster session mostly higher.

AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc. The Cambridge, England-based pharmaceutical company back in...

Fusion Pharmaceuticals (FUSN) said the Ontario Superior Court of Justice has approved its plan of arrangement to be acquired by a wholly owned subsidiary of AstraZeneca (AZN).

AstraZeneca shares target raised by Argus on new drug approvals

Earnings call: BWX Technologies reports strong Q1 growth, expansion plans

Q1 2024 results

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and...

Biotech ripe for ‘cascade of dealmaking’ - Here are the top companies to watch

NEW YORK, March 25, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

BALA CYNWYD, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.83%